Related Experiment Video
Updated: Aug 1, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Hypothyroidism. Diagnosis and management
1Department of Medicine, Albert Einstein College of Medicine, New York, USA.
Clinics in Geriatric Medicine
|May 1, 1995
Summary
Hypothyroidism is often asymptomatic in older adults, necessitating physician vigilance and consideration for laboratory screening. Careful treatment is crucial to prevent cardiac complications in this vulnerable population.
Area of Science:
- Geriatrics
- Endocrinology
- Internal Medicine
Background:
- Hypothyroidism is a common endocrine disorder, particularly prevalent in the elderly.
- Classic symptoms of hypothyroidism may be absent or atypical in aged individuals.
- Undiagnosed hypothyroidism can lead to significant morbidity in older patients.
Purpose of the Study:
- To highlight the challenges in diagnosing hypothyroidism in the elderly.
- To emphasize the importance of considering screening in this demographic.
- To underscore the need for cautious management to prevent adverse events.
Main Methods:
- Review of clinical presentations of hypothyroidism in the aged.
- Discussion of diagnostic considerations and screening strategies.
- Analysis of treatment implications and potential complications.
Main Results:
- Subtle or absent symptoms are characteristic of hypothyroidism in the elderly.
- Laboratory screening may be warranted in specific elderly subgroups or universally.
- Cardiac complications are a significant concern during treatment.
Conclusions:
- Physicians must maintain a high index of suspicion for hypothyroidism in elderly patients.
- Proactive screening and careful treatment are essential for managing hypothyroidism in this population.
- Special attention to cardiac status is required during therapeutic interventions.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...